A DNA transposon-based approach to validate oncogenic mutations in the mouse
Qin Su(Wellcome Sanger Institute), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Adam J. Dupuy(University of Iowa), Allan Bradley(Granta Design (United Kingdom)), Haydn M. Prosser(Wellcome Sanger Institute), Lia S. Campos(Universidade Federal de Minas Gerais), Nancy A. Jenkins(The University of Texas MD Anderson Cancer Center), Mariaestela Ortiz(Science Applications International Corporation (United States)), Madhuri Warren(Wellcome Sanger Institute), Neal G. Copeland(The University of Texas MD Anderson Cancer Center), Takuro Nakamura(Tokyo Medical University)
Cited by 17
Related Papers
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
|Cell|1990|1.1k
A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations
|Genome Research|2003|1k
Requirement for Wnt3 in vertebrate axis formation
|Nature Genetics|1999|904